Upload
mariana-mirela
View
213
Download
0
Embed Size (px)
Citation preview
7/30/2019 Us Gaap Consolidated Statement Ex
1/5
ACTELION LTD AND SUBSIDIARIES
CONSOLIDATED US GAAP FINANCIAL STATEMENTS FOR MARCH 31, 2004
Content:
CONSOLIDATED STATEMENTS OF OPERATIONS
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED STATEMENTS OF CASH FLOWS
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY
7/30/2019 Us Gaap Consolidated Statement Ex
2/5
ACTELION LTD AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended
March 31,
(in CHF thousands, except per share amounts) 2004 2003
Net revenue:
Products sales 97,848 60,731
Contract revenue 3,205 2,009
Total net revenue 101,053 62,740
Operating expenses
Cost of sales 9,934 6,451Research and development 29,143 18,861
Marketing and advertising 19,943 17,340
Selling, general and administration 21,839 13,752
Amortization of acquired intangible assets 440 417
Total operating expense 81,299 56,821
Operating income 19,754 5,919
Interest income 161 280
Interest expense (197) (281)Amortization of debt discount and issuance costs (1,821) -
Other financial income, net 1,407 367
Income from continuing operations before income tax
expense and share in loss of affiliate 19,304 6,285
Income tax expense (1,237) (406)
Income from continuing operations before
share in loss of affiliate 18,067 5,879
Share in loss of affiliate - (203)
Income from continuing operations 18,067 5,676
Net gain from disposal of subsidiary /
(loss from discontinued operations, net of tax
and minority interest) 9,648 (1,550)
Net income 27,715 4,126
Basic income per shareContinuing Operations 0.83 0.26
Discontinued Operations 0.44 (0.07)
Net income 1.27 0.19
Number of shares (in thousands) used in computation 21,825 21,423
Diluted income per share
Continuing Operations 0.78 0.25
7/30/2019 Us Gaap Consolidated Statement Ex
3/5
ACTELION LTD AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
March 31, December 31,(in CHF thousands, except shares and per share amounts) 2004 2003
Assets
Current assets
Cash and cash equivalents 283,409 258,770
Derivative instruments 1,098 2,199
Trade and other receivables, net 76,215 66,711
Inventories 21,155 21,455
Other current assets 7,382 3,966
Current assets of discontinued operations - 10,385
Total current assets 389,259 363,486
Property, plant and equipment, net 20,289 18,982
Other assets 7,339 6,687
Intangible assets, net 8,656 8,813
Goodwill, net 3,785 3,784
Non-current assets of discontinued operations - 1,091
Total assets 429,328 402,843
Liabilities and Shareholders' Equity
Current liabilities
Trade and other payables 25,584 27,535
Accrued expenses 37,058 37,601
Deferred revenue, current portion 17,554 10,821
Financial debt 31,214 41,161
Other current liabilities 775 2,019
Contingent consideration 6,641 6,641
Current liabilities of discontinued operations - 8,758
Total current liabilities 118,826 134,536
Long-term financial debt, less current portion 146,841 145,147
Deferred revenue, less current portion 73,282 64,468
Other non-current liabilities 1,904 1,963
Non-current liabilities of discontinued operations - 1,785
Total liabilities 340,853 347,899
Minority interest - 517
Shareholders' Equity
Common shares (par value CHF 2.50 per share, authorized
30,506,640 and 30,506,640 shares; issued 21,941,647
and 21,751,148 shares in 2004 and 2003 respectively) 54,854 54,378
Additional paid-in capital 306,983 302,817
Accumulated deficit (269,511) (297,226)
Unearned compensation (4,329) (5,369)
7/30/2019 Us Gaap Consolidated Statement Ex
4/5
ACTELION LTD AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
Three months ended
March 31,
(in CHF thousands) 2004 2003
Cash flow from operating activities
Net income 27,715 4,126
(Gain) / Loss from discontinued operations, net of minority interest (9,648) 1,550
Income from continuing operations 18,067 5,676
Adjustments to reconcile net income to net cash provided from operating
activities:
Depreciation and amortization 2,189 1,760Share in loss of affiliate - 203
Stock-based compensation 1,040 916
Realized loss on sale of marketable securities - 63
Loss on derivative instruments 1,075 652
Amortization of debt discount and expense 1,821 -
(Increase) in trade and other receivables (8,436) (12,720)
Decrease (increase) in inventories 300 (5,090)
(Increase) in other current assets (3,360) (1,461)
(Increase) in other assets (639) (250)
(Decrease) increase in trade and other payables (1,517) 4,129
(Decrease) increase in accrued expenses (905) 2,640
Increase (decrease) in deferred revenue 15,546 (1,580)(Decrease) increase in other liabilities (1,326) 32
Net cash flow provided by (used in) operating activities 23,855 (5,030)
Cash flow from investing activities
Purchase of property, plant and equipment (2,861) (1,783)
Purchase of derivative instruments (674) (1,192)
Proceeds from sale of derivative instruments 698 1,076
Purchase of intangible assets (252) (6,519)
Proceeds from sale of subsidiary 9,242 -
Net cash flow provided by (used in ) investing activities 6,153 (8,418)
Cash flows from financing activities
Payments on capital leases (60) (155)
Repayment of financial debt (10,000) -
Proceeds from exercise of stock options 4,642 627
Net cash flow provided by financing activities (5,418) 472
Net effect of exchange rates on cash and cash equivalents 49 (106)
Net effect of discontinued operations - (1,405)
Net change in cash and cash equivalents 24,639 (14,487)
Cash and cash equivalents at beginning of period 258,770 116,201
Cash and cash equivalents at end of period 283,409 101,714
7/30/2019 Us Gaap Consolidated Statement Ex
5/5
ACTELION LTD AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY
Additional Other
(in CHF thousands) Common Shares Paid-in- Accumulated Unearned Treasury Comprehensive Shareholders'
Shares Amount Capital Deficit Compensation Shares Income Equity
At January 1, 2004 21,737,648 54,378 302,817 (297,226) (5,369) (1,018) 845 54,427
Comprehensive result including tax benefit:
Net income 27,715 27,715
Other comprehensive result:
Unrealized result on marketable securities -
Currency translation adjustment 651 651
Comprehensive income 28,366
Exercise of stock options 190,499 476 4,166 4,642Stock-based compensation 1,040 1,040
At March 31, 2004 21,928,147 54,854 306,983 (269,511) (4,329) (1,018) 1,496 88,475